Medication Brand Conversion - Lignocaine 1%
Post date: Nov 29, 2017 1:45:34 AM
28th November 2017 (Circular No. SP PPUM: 439/2017):
Name of Medication: Lignocaine 1%
Company: Duopharma (M) Sdn. Bhd.
Formulary Category: Standard Formulary
UMMC's Pharmacy Department has received new stocks for Lignocaine 1% Injection (LAKAN) by Duopharma (M) Sdn. Bhd. These stocks provide an alternative to our current supply for Lignocaine 1% Injection as the current supplier, Pfizer (M) Sdn. Bhd. is facing production problems with the medication.
However, please do take note that this formulation (LAKAN Injection) can be used intramuscularly (IM) and subcutaneously (SC) only.
It can NOT be used intravenously (IV).
If the intravenous route is required, the Lignocaine 2% Injection should be considered instead.